Skip to main content

Table 2 Comparison of positive results and agreement among mNGS and CMTs in immunosuppressed patients

From: Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients

Group

NGS-positivea

NGS-negative

Total no

Kappa, agreement

CMT-positive

22

3

25

0.121, 51.6%

CMT-negative

26

9

35

 

Total no

48

12

60

 
  1. mNGS metagenomic next-generation sequencing, CMTs conventional microbiological tests
  2. aPositive: patients with a positive microbiological diagnosis
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us